Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Methods in Molecular Biology (Clifton, N.J.)|October 21, 2018
Methods to Screen Compounds Against Mutant p53 Misfolding and Aggregation for Cancer TherapeuticsGiulia Diniz da Silva Ferretti, Danielly C Ferraz da Costa, Jerson L Silva, et al.
The Journal of Physical Chemistry. B|October 25, 2022
Evolutionary Role of Water-Accessible Cavities in Src Homology 2 (SH2) DomainsGuilherme A P de Oliveira, Hiam R S Arruda, Guilherme C de Andrade, et al.
The Journal of Biological Chemistry|November 25, 2003
Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS)Yraima Cordeiro, Luís Maurício T R Lima, Mariana P B Gomes, et al.
Bioscience Reports|September 6, 2013
Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressorJerson L Silva, Luciana P Rangel, Danielly C F Costa, et al.
Accounts of Chemical Research|December 21, 2017
Targeting the Prion-like Aggregation of Mutant p53 to Combat CancerJerson L Silva, Elio A Cino, Iaci N Soares, et al.
Scientific Reports|September 8, 2016
Aggregation tendencies in the p53 family are modulated by backbone hydrogen bondsElio A Cino, Iaci N Soares, Murilo M Pedrote, et al.
The Biochemical Journal|December 17, 2019
Biophysical characterization of p53 core domain aggregatesIgor Lima, Ambuja Navalkar, Samir K Maji, et al.
Journal of Molecular Biology|May 6, 2003
Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid diseaseAstria D Ferrão-Gonzales, Leonardo Palmieri, Marcelo Valory, et al.
Molecules (Basel, Switzerland)|August 6, 2020
Bioactive Compounds and Metabolites from Grapes and Red Wine in Breast Cancer Chemoprevention and TherapyDanielly C Ferraz da Costa, Luciana Pereira Rangel, Julia Quarti, et al.
Biotechnology and Bioengineering|June 18, 2021
Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigenRenata G F Alvim, Túlio M Lima, Jerson L Silva, et al.
Pageof 15